Optimal treatment duration of neoadjuvant endocrine therapy in women aged 60 years or older with estrogen receptor-positive, HER2-negative invasive breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 30 November 2020 |
| Author/s |
author: Hiroyuki Takei Masafumi Kurosumi |
| Publication date | November 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |